Generative artificial intelligence models can alter medical recommendations based solely on a patient’s socioeconomic or demographic background — even when clinical details are identical, according to ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

For some leukemia patients, each hour of delayed care can be the difference between life and death. JHU's Eugene Shenderov is ...

TSMC produces over 90% of the world’s advanced AI chips, powering major products like Nvidia’s H100 and Google’s TPU. Learn ...

K Health's AI model is not designed to replace doctors, but rather to help them provide better care.But can it hold a ...

In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and ...

CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI ...

From diving into the ever-evolving landscape of AI in drug development to opening up the conversation to discuss regulatory hurdles and how the industry will overcome them, the Summit has been ...

Chart review has mostly been a manual process, has been prone to error, and is an area where extracting actionable insights ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...